γ-Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer’s DiseaseLutgarde Serneels, Bart De Strooper, Jérôme Van Biervliet et al.|Science|2009Cited by 260
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trialRichard Dodel, Frank Jessen, Yaroslav Winter et al.|The Lancet Neurology|2013Cited by 185
Development and Technical Validation of an Immunoassay for the Detection of APP669–711 (Aβ−3–40) in Biological SamplesHans‐Wolfgang Klafki, Jens Wiltfang|International Journal of Molecular Sciences|2020Cited by 30